Matthew D’Ambrosio

Standing Tall with Chemical & Mining Co. of Chile

Thanks for commenting. Owning both SQM and POT would not give you much diversification if you were to go that route why not look at MOO for a whole-sector play.

SQM is pulling back now as you can clearly see however,
the perfect entry point seems to be right around $20 if you can time stocks that well. This was the last buy signal from my indicators from four months ago after a rapid decline in share price.

As for POT alone, the indicators that I look at show a buy signal in the high $70's or low 80's at this point in time. These indicatiors could show to sell at some further point out but all indications are that this stock will continue to move up (that's odd in and of itself nowadays)so at this price looks very attractive.

Hope this helps.


On Mar 09 09:03 AM Gravity404 wrote:

> I really like SQM and have been following it for a while; waiting
> for it to pull back some but it hasn't.
>
> Question: Since POT owns app. 35% of SQM, it's a good play to buy
> POT in the mid to low 60s like it is? And get both??

Wednesday Outlook: Commodities, Emerging Markets

For whatever this is worth to you but I, like the relpy earlier, really enjoy your graphs and commentary that is done in a non-bias manner. Keep up the good work.

Critical Therapeutics Awaits FDA Decision on New Zyflo Formulation

You might want to re-think how one chooses stocks on small, up-start pharmaceutical companies without inherently knowing alittle more about the company, i.e. company outlook, sales ability, target market, and more to the point - competition rather then JUST the science behind a particular drug. CRTX stock is being delisted from NASDAQ.